Search - tctmd.com

Displaying 141 - 160 of 484

Sort: Relevancy | Date

News Daily News

Multivessel Disease Patients See Benefits of Long-term Ticagrelor: PEGASUS-TIMI 54 Analysis

Yael L. Maxwell

January 31, 2018

News Daily News

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Michael O'Riordan

December 14, 2017

Presentation TCT 2017

Heart Team Evidence: Synthesizing the PCI vs CABG Left Main Data From EXCEL, NOBLE, and SYNTAX

Presenter: James B. Hermiller Jr., John D. Puskas, Bernard J. Gersh

November 01, 2017

Presentation TCT 2017

Debate: Based on EXCEL and NOBLE, PCI Should Become Class IA for Left Main Revascularization If Technically Feasible, at Least in Intermediate and Low SYNTAX Score Patients!

Presenter: Evald H. Christiansen, Erick Schampaert, Marco V. Wainstein

October 31, 2017

REVASCTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

News Conference News TCT 2017

REVASC: CTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

Todd Neale

October 31, 2017

Presentation TCT 2017

SYNTAX II: Contemporary Outcomes of PCI in 3VD

Presenter: Fernando Alfonso, Patrick W. Serruys, Adrian P. Banning

October 30, 2017

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

News Conference News ESC 2017

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Todd Neale

August 26, 2017

News Daily News

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

Todd Neale

July 20, 2017

News Conference News EuroPCR 2017

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

Michael O'Riordan

May 19, 2017

News Conference News EuroPCR 2017

EUROCTO: Revascularization Bests Medical Therapy for Quality of Life in CTO Lesions

Yael L. Maxwell

May 18, 2017

News Opinion Fellow Talk

The Left Main Debate: What Does it Mean for the Future of Intervention?

Tiffany Patterson, MBBS

April 12, 2017

News Daily News

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Michael O'Riordan

March 29, 2017

News Daily News

After EXCEL and NOBLE, New Meta-analysis Revisits PCI vs Surgery for Unprotected Left Main CAD

Michael O'Riordan

December 14, 2016

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

News Opinion Editor's Corner TCT 2016

我对 2016 年 TCT 的总结：惊喜、假设和赠品

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Shelley Wood

November 07, 2016

Presentation TCT 2016

Case Conclusion: How Did I Treat?

Presenter: Runlin Gao, Bo Xu, Junjie Zhang

November 01, 2016

Advertisement

Multivessel Disease Patients See Benefits of Long-term Ticagrelor: PEGASUS-TIMI 54 Analysis

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Heart Team Evidence: Synthesizing the PCI vs CABG Left Main Data From EXCEL, NOBLE, and SYNTAX

Debate: Based on EXCEL and NOBLE, PCI Should Become Class IA for Left Main Revascularization If Technically Feasible, at Least in Intermediate and Low SYNTAX Score Patients!

REVASC: CTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

SYNTAX II: Contemporary Outcomes of PCI in 3VD

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

EUROCTO: Revascularization Bests Medical Therapy for Quality of Life in CTO Lesions

The Left Main Debate: What Does it Mean for the Future of Intervention?

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

After EXCEL and NOBLE, New Meta-analysis Revisits PCI vs Surgery for Unprotected Left Main CAD

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

我对 2016 年 TCT 的总结：惊喜、假设和赠品

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Case Conclusion: How Did I Treat?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content